These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5770114)

  • 1. Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine.
    Vogel CL; Calabresi P
    Proc Soc Exp Biol Med; 1969 May; 131(1):251-6. PubMed ID: 5770114
    [No Abstract]   [Full Text] [Related]  

  • 2. ENHANCED SUPPRESSION OF THE SECONDARY IMMUNE RESPONSE BY COMBINATION OF 6-MERCAPTOPURINE DUAZOMYCIN A'.
    ROSENBERG S; CALABRESI P
    Nature; 1963 Sep; 199():1101-2. PubMed ID: 14066954
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and pharmacologic effects of combinations of 6-thioguanine and duazomycin A in patients with neoplastic disease.
    Lefkowitz ER; Creasey WA; Calabresi P; Sartorelli AC
    Cancer Res; 1965 Sep; 25(8):1207-12. PubMed ID: 5839715
    [No Abstract]   [Full Text] [Related]  

  • 4. [The suppression of experimental allergic encephalomyelitis by heterologous antilymphocyte serum and antimetabolites].
    Fischer W; Müller J
    Acta Biol Med Ger; 1970; 25(1):197-200. PubMed ID: 5489676
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of advanced Wegener's granulomatosis with azathioprine and duazomycin A.
    Kaplan SR; Hayslett JP; Calabresi P
    N Engl J Med; 1968 Feb; 278(5):239-44. PubMed ID: 5635457
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations in patients with metastatic malignancy treated with duazomycin A.
    Colsky J; Shnider BI; Franzino A; Perez J
    Clin Pharmacol Ther; 1966; 7(3):352-8. PubMed ID: 4957007
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone.
    Levine S; Saltzman A
    J Neuroimmunol; 1986 Dec; 13(2):175-81. PubMed ID: 3491090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mercaptopurine and silylated mercaptopurine the treatment of experimental allergic encephalomyelitis].
    Vohl ML; Westarp ME; Wekerle H; Gerlach M; Jutzi P; Przuntek H
    Arzneimittelforschung; 1990 Jan; 40(1):80-4. PubMed ID: 2340004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Can J Biochem; 1970 Jan; 48(1):79-83. PubMed ID: 5512546
    [No Abstract]   [Full Text] [Related]  

  • 10. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 6-mercaptopurine on susceptibility of guinea pigs to experimental allergic encephalomyelitis.
    THOMSON JD; AUSTIN RW
    Proc Soc Exp Biol Med; 1962 Oct; 111():121-3. PubMed ID: 13981230
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of experimental allergic encephalomyelitis with 6-mercaptopurine.
    HOYER LW; CONDIE RM; GOOD RA
    Proc Soc Exp Biol Med; 1960 Jan; 103():205-7. PubMed ID: 14403523
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of experimental allergic encephalomyelitis with myelin basic protein: which route is best?
    Levine S; Sowinski R
    Neurochem Res; 1984 Oct; 9(10):1417-21. PubMed ID: 6083467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of immunoglobulin treatment in rats with experimental allergic encephalomyelitis].
    Mel'nyk VO; Lisianyĭ MI; Biel's'ka LM; Shniakin SA
    Fiziol Zh (1994); 2005; 51(6):37-9. PubMed ID: 16485852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy.
    Lichtenstein GR
    Gastroenterology; 2004 Nov; 127(5):1558-64. PubMed ID: 15521022
    [No Abstract]   [Full Text] [Related]  

  • 16. INTRODUCTORY REMARKS: SUPPRESSION OF DEMYELINATING DISEASE.
    KIBLER RF
    Ann N Y Acad Sci; 1965 Mar; 122():332. PubMed ID: 14313492
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.
    Levine S; Sowinski R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):309-18. PubMed ID: 603323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn disease.
    Chehade M; Benkov K
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):120-1. PubMed ID: 11321377
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis.
    Arnason BG; Richman DP
    Trans Am Neurol Assoc; 1969; 94():54-8. PubMed ID: 5374490
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of some immunosuppressive and anti-inflammotory drugs on allergic encephalomyelitis and adjuvant arthritis.
    Rosenthale ME; Nagra CL
    Proc Soc Exp Biol Med; 1967 May; 125(1):149-53. PubMed ID: 6027515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.